The Medical Strategy Lead will provide senior clinical and scientific expertise to all IQVIA divisions as requested and will collaborate closely with indication-specific teams to develop integrated strategies for CNS clinical trials, mostly Phases 1-3. The Medical Strategy Lead will also be responsible for early engagement business development activities, providing scientific knowledge and expertise to guide sponsors in CNS clinical development. As a subject matter expert, the Medical Strategy Lead will drive thought leadership activities including presentations, publications, and interactions with the medical scientific community.
Postgraduate qualification preferred.12+ years of relevant commercial experience in international biopharmaceuticals, including extensive strategic and operational marketingPossesses strong commercial acumen, and the ability to manage multiple priorities, processes, timelines, and expectations across diverse stakeholder groupsExperience in leading strategic processes for portfolio and brand development, including investment and resource allocationExperience leading global marketing initiatives and managing diverse, multicultural matrix teamsExperience in P&L management & ideally as a General Manager requested to realise the value of expected portfolio and brand growthDemonstrated ability to lead, influence and inspire cross-functional matrix teams, driving collaboration, innovation and results at a global, region and local levelProficiency in CRM systems and tools, with a focus on leveraging data-driven insights to drive customer engagement and retentionStrong strategic and analytical capabilities, with the ability to translate market insights into actionable marketing strategies and tacticsExcellent project management skills, with a track record of successfully managing complex, multi-stakeholder projects from inception to implementationAn excellent command of the English language (spoken and written) is required About CSL Vifor CSL Vifor is a global partner of choice for pharmaceuticals and innovative, leading therapies in iron deficiency and nephrology.